Clinical Trial Update: Neoadjuvant Prolgolimab Monotherapy in Locally Advanced MMR-deficient Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on neoadjuvant prologolimab monotherapy for locally advanced MMR-deficient colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• prologolimab (prologolimab)

Snippet

Sponsor: Blokhin's Russian Cancer Research Center | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED